A Rare Case of Spontaneous Bladder Rupture in a Herpes Zoster Patient.
Huang J, Tai S, Ding H, Xu L, Hua R, Yu Y, Mao D.
Infect Drug Resist. 2022 Sep 5;15:5193-5196. doi: 10.2147/IDR.S380752. eCollection 2022.
Oncolytic virus therapy: A new era of cancer treatment at dawn.
Fukuhara H, Ino Y, Todo T.
Cancer Sci. 2016 Oct;107(10):1373-1379. doi: 10.1111/cas.13027. Epub 2016 Sep 9.
Association of human herpes, papilloma and polyoma virus families with bladder cancer.
Panagiotakis GI, Papadogianni D, Chatziioannou MN, Lasithiotaki I, Delakas D, Spandidos DA.
Tumour Biol. 2013 Feb;34(1):71-9. doi: 10.1007/s13277-012-0512-2. Epub 2012 Sep 13.
Oncolytic Viruses for the Treatment of Bladder Cancer: Advances, Challenges, and Prospects.
Hu H, Xia Q, Hu J, Wang S.
J Clin Med. 2022 Nov 26;11(23):6997. doi: 10.3390/jcm11236997.
The effect of herpes simplex virus vector-mediated gene therapy of protein phosphatase 1alpha on bladder overactivity and nociception.
Majima T, Mori K, Kadekawa K, Takai S, Funahashi Y, Reinhart B, Goins WF, Gotoh M, Glorioso JC, Yoshimura N.
Neurourol Urodyn. 2019 Feb;38(2):582-590. doi: 10.1002/nau.23882. Epub 2018 Nov 29.
Infection: is it a cause of bladder cancer?
Abol-Enein H.
Scand J Urol Nephrol Suppl. 2008 Sep;(218):79-84. doi: 10.1080/03008880802325309.
Herpes Simplex Virus Vector-Mediated Gene Delivery of Poreless TRPV1 Channels Reduces Bladder Overactivity and Nociception in Rats.
Majima T, Funahashi Y, Takai S, Goins WF, Gotoh M, Tyagi P, Glorioso JC, Yoshimura N.
Hum Gene Ther. 2015 Nov;26(11):734-42. doi: 10.1089/hum.2015.026. Epub 2015 Aug 31.
Effects of herpes simplex virus vector-mediated enkephalin gene therapy on bladder overactivity and nociception.
Yokoyama H, Oguchi T, Goins WF, Goss JR, Nishizawa O, de Groat WC, Wolfe D, Krisky DM, Glorioso JC, Yoshimura N.
Hum Gene Ther. 2013 Feb;24(2):170-80. doi: 10.1089/hum.2011.180. Epub 2013 Feb 14.
Morphological changes in different populations of bladder afferent neurons detected by herpes simplex virus (HSV) vectors with cell-type-specific promoters in mice with spinal cord injury.
Shimizu N, Doyal MF, Goins WF, Kadekawa K, Wada N, Kanai AJ, de Groat WC, Hirayama A, Uemura H, Glorioso JC, Yoshimura N.
Neuroscience. 2017 Nov 19;364:190-201. doi: 10.1016/j.neuroscience.2017.09.024. Epub 2017 Sep 20.
Abrogation of USP7 is an alternative strategy to downregulate PD-L1 and sensitize gastric cancer cells to T cells killing.
Wang Z, Kang W, Li O, Qi F, Wang J, You Y, He P, Suo Z, Zheng Y, Liu HM.
Acta Pharm Sin B. 2021 Mar;11(3):694-707. doi: 10.1016/j.apsb.2020.11.005. Epub 2020 Nov 16.
